Critical initiated by Global Crown at overweight

Critical Therapeutics Inc. coverage was initiated by Global Crown Capital analyst Kate Winkler at an overweight rating. Critical Therapeutics has a diverse pipeline of anti-inflammatory agents with a potential blockbuster in Zyflo (zileuton), Global Crown said. Critical Therapeutics shares Tuesday slipped $0.05, or 0.74%, to $6.71 on volume of 28,116 shares versus the three-month running average of 22,240 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.